ES2104518T1
(es)
*
|
1994-03-07 |
1997-10-16 |
Dow Chemical Co |
Conjugados dendrimeros bioactivos y/o directores hacia diana.
|
BE1008134A3
(nl)
*
|
1994-03-16 |
1996-01-23 |
Dsm Nv |
Bereiding van stervormig vertakte polymeren.
|
GB9421282D0
(en)
*
|
1994-10-21 |
1994-12-07 |
Exxon Chemical Patents Inc |
Additives and oleaginous compositions
|
US5561214A
(en)
*
|
1995-05-18 |
1996-10-01 |
Bayer Corporation |
Hyperbranched polyaspartate esters and a process for their preparation
|
US5830986A
(en)
*
|
1996-10-28 |
1998-11-03 |
Massachusetts Institute Of Technology |
Methods for the synthesis of functionalizable poly(ethylene oxide) star macromolecules
|
US6255424B1
(en)
|
1997-11-25 |
2001-07-03 |
Colorado School Of Mines |
Dendritic polymers and convergent method of synthesis
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
KR100719202B1
(ko)
|
1998-10-23 |
2007-05-16 |
키린-암젠 인코포레이티드 |
MPl 수용체에 결합하는 화합물 및 이를 함유하는 제약학적 조성물
|
JP3181276B2
(ja)
*
|
1999-08-31 |
2001-07-03 |
科学技術振興事業団 |
樹枝状分岐構造を持つ両親媒性化合物
|
AU4830901A
(en)
|
2000-02-09 |
2001-08-20 |
Ciba Specialty Chemicals Holding Inc. |
Hyperbranched amphiphilic polymeric additives and polymer compositions with increased surface energy
|
ATE319737T1
(de)
|
2000-04-21 |
2006-03-15 |
Amgen Inc |
Peptidderivate des apolipoproteins-a1/aii
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6677136B2
(en)
|
2000-05-03 |
2004-01-13 |
Amgen Inc. |
Glucagon antagonists
|
CA2408617A1
(en)
|
2000-05-12 |
2001-11-22 |
Amgen Inc. |
Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
|
US6407169B1
(en)
*
|
2000-12-13 |
2002-06-18 |
The University Of Waterloo |
Method for synthesis of graft polymers
|
JP4511075B2
(ja)
*
|
2001-04-23 |
2010-07-28 |
レンゴー株式会社 |
含硫ウレタン系デンドリマー及びその製造方法
|
EA010435B1
(ru)
|
2001-05-11 |
2008-08-29 |
Амген, Инк. |
Связывающиеся с tall-1 молекулы и их применение
|
WO2002092668A1
(en)
|
2001-05-17 |
2002-11-21 |
Ciba Specialty Chemicals Holding Inc. |
Polymer additives with improved permanence and surface affinity
|
US7332474B2
(en)
|
2001-10-11 |
2008-02-19 |
Amgen Inc. |
Peptides and related compounds having thrombopoietic activity
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
JP3984541B2
(ja)
*
|
2001-12-26 |
2007-10-03 |
財団法人川村理化学研究所 |
星型ポリオキサゾリンからなる粒子およびその製造方法
|
ES2737837T3
(es)
|
2003-10-09 |
2020-01-16 |
Ambrx Inc |
Derivados poliméricos
|
WO2005044188A2
(en)
|
2003-10-27 |
2005-05-19 |
Amgen Inc. |
Compositions and methods to modulate an immune response to an immunogenic therapeutic agent
|
CA2553040A1
(en)
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human four helical bundle polypeptides and their uses
|
USRE44638E1
(en)
|
2004-05-13 |
2013-12-10 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
KR20070034512A
(ko)
|
2004-06-18 |
2007-03-28 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
US8143380B2
(en)
|
2004-07-08 |
2012-03-27 |
Amgen Inc. |
Therapeutic peptides
|
WO2006016648A1
(ja)
*
|
2004-08-13 |
2006-02-16 |
Nippon Soda Co., Ltd. |
スターポリマー、酸分解性樹脂組成物、レジスト組成物およびジ(メタ)アクリレート化合物
|
SG160437A1
(en)
|
2004-12-22 |
2010-04-29 |
Ambrx Inc |
Modified human growth hormone
|
CA2590590C
(en)
|
2004-12-22 |
2016-04-19 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
CN101087875B
(zh)
|
2004-12-22 |
2012-08-22 |
Ambrx公司 |
氨酰基-tRNA合成酶的组合物及其用途
|
AU2005322019B2
(en)
|
2004-12-22 |
2010-08-26 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
MX2007007591A
(es)
|
2004-12-22 |
2007-07-25 |
Ambrx Inc |
Metodos para expresion y purificacion de hormona de crecimiento humano recombinante.
|
EP1907452B1
(de)
|
2005-05-21 |
2017-04-05 |
University Of Durham |
Neue oberflächenaktive polymer-dendron-systeme
|
JP2008541769A
(ja)
|
2005-06-03 |
2008-11-27 |
アンブレツクス・インコーポレイテツド |
改善されたヒトインターフェロン分子及びそれらの使用
|
WO2006138145A1
(en)
|
2005-06-14 |
2006-12-28 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
NZ597082A
(en)
|
2005-10-13 |
2013-11-29 |
Human Genome Sciences Inc |
Methods and Compositions for Use in Treatment of Patients with Autoantibody Positive Diseases
|
PL1940916T3
(pl)
|
2005-10-25 |
2017-07-31 |
Starpharma Pty Limited |
Związki wielocząsteczkowe o kontrolowanej stechiometrii
|
AR056806A1
(es)
|
2005-11-14 |
2007-10-24 |
Amgen Inc |
Moleculas quimericas de anticuerpo rankl- pth/ pthrp
|
KR20080079643A
(ko)
|
2005-11-16 |
2008-09-01 |
암브룩스, 인코포레이티드 |
비-천연 아미노산을 포함하는 방법 및 조성물
|
US9012605B2
(en)
|
2006-01-23 |
2015-04-21 |
Amgen Inc. |
Crystalline polypeptides
|
DE602007009954D1
(de)
|
2006-03-22 |
2010-12-02 |
Viral Logic Systems Technology |
Verfahren zur identifizierung von polypeptid-targets
|
US8129334B2
(en)
|
2006-03-31 |
2012-03-06 |
The Regents Of The University Of California |
Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
|
US8377448B2
(en)
|
2006-05-15 |
2013-02-19 |
The Board Of Trustees Of The Leland Standford Junior University |
CD47 related compositions and methods for treating immunological diseases and disorders
|
US7981425B2
(en)
|
2006-06-19 |
2011-07-19 |
Amgen Inc. |
Thrombopoietic compounds
|
ATE540681T1
(de)
|
2006-06-26 |
2012-01-15 |
Amgen Inc |
Verfahren zur behandlung von atherosklerose
|
US20080020043A1
(en)
*
|
2006-07-20 |
2008-01-24 |
Marc Gingras |
Dendrimer-Drug Conjugates
|
DK2615108T3
(en)
|
2006-09-08 |
2017-01-30 |
Ambrx Inc |
Modified human plasma polypeptide or fc scaffolds and their applications
|
CA2662753C
(en)
|
2006-09-08 |
2016-02-23 |
Ambrx, Inc. |
Hybrid suppressor trna for vertebrate cells
|
WO2008030614A2
(en)
|
2006-09-08 |
2008-03-13 |
Ambrx, Inc. |
Suppressor trna transcription in vertebrate cells
|
AU2007323836B2
(en)
|
2006-11-13 |
2013-04-18 |
Icos Corporation |
Thienopyrimidinones for treatment of inflammatory disorders and cancers
|
CN103966345A
(zh)
|
2007-02-09 |
2014-08-06 |
西北大学 |
检测细胞内标靶的颗粒
|
JP5288363B2
(ja)
*
|
2007-02-16 |
2013-09-11 |
国立大学法人九州大学 |
デンドロンとメソゲンとを有する化合物、液晶組成物及び光素子
|
AU2008232937B2
(en)
|
2007-03-30 |
2012-09-27 |
Ambrx, Inc. |
Modified FGF-21 polypeptides and their uses
|
US8114630B2
(en)
|
2007-05-02 |
2012-02-14 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
AU2008259907B2
(en)
|
2007-05-30 |
2014-12-04 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
EP2522721B1
(de)
|
2007-07-26 |
2016-05-04 |
Amgen, Inc |
Modifizierte Lecithin-Cholesterin-Acyltransferase-Enzyme
|
JP5547083B2
(ja)
|
2007-11-20 |
2014-07-09 |
アンブルックス,インコーポレイテッド |
修飾されたインスリンポリペプチドおよびそれらの使用
|
CA2712606A1
(en)
|
2008-02-08 |
2009-08-13 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
AU2009262199B2
(en)
|
2008-06-27 |
2012-08-09 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
JP2011526916A
(ja)
|
2008-06-30 |
2011-10-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
全身性紅斑性狼瘡を同定および処置するための診断標的および治療標的としてのリソソームホスホリパーゼa2(lpla2)活性
|
NZ591235A
(en)
|
2008-07-23 |
2012-07-27 |
Ambrx Inc |
Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
|
TR201802361T4
(tr)
|
2008-09-26 |
2018-03-21 |
Ambrx Inc |
Doğal olmayan amino asit replikasyonuna bağımlı mikroorganizmalar ve aşılar.
|
EP2342223B1
(de)
|
2008-09-26 |
2017-04-26 |
Ambrx, Inc. |
Modifizierte tiererythropoietinpolypeptide und anwendungen davon
|
US9815712B2
(en)
|
2008-10-03 |
2017-11-14 |
California Institute Of Technology |
High capacity perchlorate-selective resins from hyperbranched macromolecules
|
WO2010040117A2
(en)
*
|
2008-10-03 |
2010-04-08 |
California Institute Of Technology |
Extraction of anions from solutions and mixtures using hyperbranched macromolecules
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
ES2674719T3
(es)
|
2008-11-13 |
2018-07-03 |
Gilead Calistoga Llc |
Terapias para neoplasias hematológicas
|
DK2365803T3
(en)
|
2008-11-24 |
2018-01-22 |
Univ Northwestern |
POLYVALENT RNA NANOPARTICLE COMPOSITIONS
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
NZ595307A
(en)
|
2009-03-24 |
2013-11-29 |
Gilead Calistoga Llc |
Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
JP2012524126A
(ja)
|
2009-04-20 |
2012-10-11 |
ギリアド カリストガ リミテッド ライアビリティ カンパニー |
固形腫瘍の治療方法
|
CA2765688A1
(en)
|
2009-06-19 |
2010-12-23 |
Medimmune, Llc |
Protease variants
|
JP5376543B2
(ja)
*
|
2009-07-01 |
2013-12-25 |
独立行政法人科学技術振興機構 |
ポリイオンデンドリマー、及びそれよりなるハイドロゲル
|
EA201270184A1
(ru)
|
2009-07-21 |
2012-08-30 |
ГИЛИЭД КАЛИСТОГА ЭлЭлСи |
Лечение расстройств печени ингибиторами pi3k
|
US20120183546A1
(en)
|
2009-09-23 |
2012-07-19 |
Amgen Inc. |
Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
WO2011049625A1
(en)
|
2009-10-20 |
2011-04-28 |
Mansour Samadpour |
Method for aflatoxin screening of products
|
JP5866119B2
(ja)
|
2009-10-30 |
2016-02-17 |
ノースウェスタン ユニバーシティ |
鋳型ナノ複合体
|
CN105801550B
(zh)
|
2009-11-05 |
2019-06-14 |
理森制药股份公司 |
新型苯并吡喃激酶调节剂
|
WO2011084719A2
(en)
|
2009-12-17 |
2011-07-14 |
California Institute Of Technology |
Soluble anion exchangers from hyperbranched macromolecules
|
AU2010341518B2
(en)
|
2009-12-21 |
2014-01-09 |
Ambrx, Inc. |
Modified porcine somatotropin polypeptides and their uses
|
WO2011087808A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
ES2460944T3
(es)
*
|
2010-01-20 |
2014-05-16 |
Basf Se |
Procedimiento para la preparación de una dispersión acuosa de polímero
|
CA2799177A1
(en)
|
2010-05-14 |
2011-11-17 |
Amgen Inc. |
Enhanced death receptor agonists
|
DK2571878T3
(en)
|
2010-05-17 |
2019-02-11 |
Indian Incozen Therapeutics Pvt Ltd |
Hitherto unknown 3,5-DISUBSTITUTED-3H-IMIDAZO [4,5-B] PYRIDINE AND 3,5- DISUBSTITUTED -3H- [1,2,3] TRIAZOL [4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN CHINES
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
KR101963460B1
(ko)
|
2010-08-17 |
2019-03-28 |
암브룩스, 인코포레이티드 |
변형된 릴랙신 폴리펩타이드 및 그것의 용도
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
JP6118314B2
(ja)
|
2011-05-04 |
2017-04-19 |
ライゼン・ファーマシューティカルズ・エスアー |
タンパク質キナーゼのモジュレーターとしての新規化合物
|
WO2013040499A1
(en)
|
2011-09-14 |
2013-03-21 |
Northwestern University |
Nanoconjugates able to cross the blood-brain barrier
|
AR090253A1
(es)
|
2012-03-05 |
2014-10-29 |
Gilead Calistoga Llc |
Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluor-3-fenilquinazolin-4(3h)-ona
|
WO2013138494A1
(en)
|
2012-03-13 |
2013-09-19 |
California Institute Of Technology |
Periodic nanostructures from self assembled wedge-type block-copolymers
|
US9382387B2
(en)
|
2012-03-13 |
2016-07-05 |
California Institute Of Technology |
Rapid self-assembly of block copolymers to photonic crystals
|
AU2013239682B2
(en)
|
2012-03-28 |
2016-03-31 |
Amgen Inc. |
DR5 receptor agonist combinations
|
KR20140144726A
(ko)
|
2012-03-30 |
2014-12-19 |
리젠 파마슈티컬스 소시에떼 아노님 |
C-met 단백질 키나제의 조절제로서의 신규한 3,5-디치환-3h-이미다조[4,5-b]피리딘 및 3,5- 디치환 -3h-[1,2,3]트리아졸로[4,5-b] 피리딘 화합물
|
EP3505534A1
(de)
|
2012-06-08 |
2019-07-03 |
Sutro Biopharma, Inc. |
Antikörper mit nichtnatürlichen stellenspezifischen aminosäureresten, verfahren zu deren herstellung und verfahren zu deren verwendung
|
ES2611788T3
(es)
|
2012-06-26 |
2017-05-10 |
Sutro Biopharma, Inc. |
Proteínas de Fc modificadas que comprenden residuos de aminoácidos no naturales específicos del sitio, conjugados de las mismas, métodos para su preparación y métodos para su uso
|
US20150344549A1
(en)
|
2012-06-27 |
2015-12-03 |
The Trustees Of Princeton University |
Split inteins, conjugates and uses thereof
|
US9453943B2
(en)
|
2012-06-28 |
2016-09-27 |
California Institute Of Technology |
Photonic structures from self assembly of brush block copolymers and polymer blends
|
AU2013308494B2
(en)
|
2012-08-31 |
2018-03-01 |
Sutro Biopharma, Inc. |
Modified amino acids comprising an azido group
|
JP6679311B2
(ja)
|
2013-02-04 |
2020-04-15 |
ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated |
基板用コーティング
|
US9272075B2
(en)
|
2013-02-04 |
2016-03-01 |
W.L. Gore & Associates, Inc. |
Coating for substrate
|
ES2865473T3
(es)
|
2013-07-10 |
2021-10-15 |
Sutro Biopharma Inc |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
JP6255210B2
(ja)
*
|
2013-10-24 |
2017-12-27 |
アーゼッド・エレクトロニック・マテリアルズ(ルクセンブルグ)ソシエテ・ア・レスポンサビリテ・リミテ |
レジスト下層膜形成組成物
|
EA201690990A1
(ru)
|
2013-12-20 |
2016-11-30 |
Джилид Калистога Ллс |
Способы получения ингибиторов фосфатидилинозитол-3-киназы
|
AU2014364414A1
(en)
|
2013-12-20 |
2016-06-30 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
|
CA2952012A1
(en)
|
2014-06-13 |
2015-12-17 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
JP6702962B2
(ja)
|
2014-10-24 |
2020-06-03 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
改変fgf−21ポリペプチドおよびその使用
|
CA2968309A1
(en)
|
2014-11-19 |
2016-05-26 |
NZP UK Limited |
6-alkyl-7-hydroxy-4-en-3-one steroids as intermediates for the production of steroidal fxr modulators
|
EA034739B1
(ru)
|
2014-11-19 |
2020-03-16 |
ЭнЗедПи ЮКей ЛИМИТЕД |
6-альфа-алкил-3,7-дионовые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
|
TWI686400B
(zh)
|
2014-11-19 |
2020-03-01 |
英商Nzp英國有限公司 |
化合物(二)
|
CN107207558B
(zh)
|
2014-11-19 |
2019-10-29 |
Nzp英国有限公司 |
作为制备类固醇FXR调节剂的中间体的6α-烷基-6,7-二酮类固醇
|
US11213593B2
(en)
|
2014-11-21 |
2022-01-04 |
Northwestern University |
Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
US10608280B2
(en)
|
2015-03-09 |
2020-03-31 |
California Institute Of Technology |
Brush block copolymer electrolytes and electrocatalyst compositions
|
US20170157215A1
(en)
|
2015-12-04 |
2017-06-08 |
Jomoco, Corp. |
Compositions and methods to mitigate or prevent an immune response to an immunogenic therapeutic molecule in non-human primates
|
SG11201806419RA
(en)
|
2016-01-27 |
2018-08-30 |
Sutro Biopharma Inc |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
GB201608776D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Methods and compounds
|
GB201608777D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Compounds
|
WO2018148419A1
(en)
|
2017-02-08 |
2018-08-16 |
Bristol-Myers Squibb Company |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
JP6844773B2
(ja)
*
|
2017-03-01 |
2021-03-17 |
国立大学法人 岡山大学 |
細胞内導入機能を有するホウ素を含むデンドリマー
|
US11053356B2
(en)
|
2017-03-07 |
2021-07-06 |
California Institute Of Technology |
Control of polymer architectures by living ring-opening metathesis copolymerization
|
WO2019023316A1
(en)
|
2017-07-26 |
2019-01-31 |
Sutro Biopharma, Inc. |
METHODS OF USING ANTI-CD74 ANTIBODIES AND ANTIBODY CONJUGATES IN THE TREATMENT OF A T CELL LYMPHOMA
|
CA3075087A1
(en)
|
2017-09-18 |
2019-03-21 |
Sutro Biopharma, Inc. |
Anti- folate receptor alpha antibody conjugates and their uses
|
CN116948006A
(zh)
|
2018-09-11 |
2023-10-27 |
北京泰德制药股份有限公司 |
白介素-2多肽偶联物及其用途
|
WO2020060944A1
(en)
|
2018-09-17 |
2020-03-26 |
Sutro Biopharma, Inc. |
Combination therapies with anti-folate receptor antibody conjugates
|
US20220009986A1
(en)
|
2018-10-19 |
2022-01-13 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
|
AU2020223031A1
(en)
|
2019-02-12 |
2021-08-19 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-TLR agonist conjugates
|
US20220362394A1
(en)
|
2019-05-03 |
2022-11-17 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
WO2020252043A1
(en)
|
2019-06-10 |
2020-12-17 |
Sutro Biopharma, Inc. |
5H-PYRROLO[3,2-d]PYRIMIDINE-2,4-DIAMINO COMPOUNDS AND ANTIBODY CONJUGATES THEREOF
|
US20220259202A1
(en)
|
2019-06-17 |
2022-08-18 |
Sutro Biopharma, Inc. |
1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis
|
EP4114852A1
(de)
|
2020-03-03 |
2023-01-11 |
Sutro Biopharma, Inc. |
Antikörper mit stellenspezifischen glutamin-tags, verfahren zu ihrer herstellung und verfahren zu ihrer verwendung
|
CA3174114A1
(en)
|
2020-03-11 |
2021-09-16 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
JP2023538071A
(ja)
|
2020-08-20 |
2023-09-06 |
アンブルックス,インコーポレイテッド |
抗体-tlrアゴニストコンジュゲート、その方法及び使用
|
WO2022103983A2
(en)
|
2020-11-11 |
2022-05-19 |
Sutro Biopharma, Inc. |
Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use
|
JP2024512775A
(ja)
|
2021-04-03 |
2024-03-19 |
アンブルックス,インコーポレイテッド |
抗her2抗体薬物コンジュゲート及びその使用
|
AR125490A1
(es)
|
2021-04-30 |
2023-07-19 |
Celgene Corp |
Terapias de combinación que utilizan un anticuerpo anti-bcma conjugado a fármaco (adc) en combinación con un inhibidor de gamma secretasa (gsi)
|
WO2024006272A1
(en)
|
2022-06-27 |
2024-01-04 |
Sutro Biopharma, Inc. |
β-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF
|
US20240058465A1
(en)
|
2022-06-30 |
2024-02-22 |
Sutro Biopharma, Inc. |
Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates
|
WO2024015229A1
(en)
|
2022-07-15 |
2024-01-18 |
Sutro Biopharma, Inc. |
Protease/enzyme cleavable linker-payloads and protein conjugates
|
WO2024044780A1
(en)
|
2022-08-26 |
2024-02-29 |
Sutro Biopharma, Inc. |
Interleukin-18 variants and uses thereof
|
WO2024098023A2
(en)
|
2022-11-04 |
2024-05-10 |
Sutro Biopharma, Inc. |
Interferon alpha polypeptides and conjugates
|